Addictions CAG Publications 2018 Addendum
Anderson B.M. Dutton M. Day E. Jackson T.A. Ferro C.J. Sharif A. (2018). Frailty Intervention Trial iN End-Stage patientS on haemodialysis (FITNESS): study protocol for a randomised controlled trial. Trials.19(1):457. doi: 10.1186/s13063-018-2842-x.
Baker A.L. Robson D. Lawn S. Steinberg M.L. Bucci S. McNeill A. Castle D.J. Bonevski B. (2018). Reducing smoking among people with schizophrenia: Perspectives on priorities for advancing research. Frontiers in Psychiatry. 9:711. doi: 10.3389/fpsyt.2018.00711.
Campbell G. Hall W. Nielsen S. (2018). What does the ecological and epidemiological evidence indicate about the potential for cannabinoids to reduce opioid use and harms? A comprehensive review. International Review of Psychiatry. 1-16. doi: 10.1080/09540261.2018.1509842.
Campbell G. Hall W. Degenhardt L. Dobbins T. Farrell M. (2018). Cannabis use and non-cancer chronic pain - Authors' reply. Lancet Public Health. 3(10):e469. doi: 10.1016/S2468-2667(18)30182-8.
Chan G. Morphett K. Gartner C. Leung J. Yong H.H. Hall W. Borland R. (2018). Predicting vaping uptake, vaping frequency and ongoing vaping among daily smokers using longitudinal data from the International Tobacco Control (ITC) Four Country Surveys. Addiction. doi: 10.1111/add.14537. [Epub ahead of print].
Davis C.N. Slutske W.S. Martin N.G. Agrawal A. Lynskey M.T. (2018). Genetic and environmental influences on gambling disorder liability: a replication and combined analysis of two twin studies. Psychological Medicine. 2018 Aug 30:1-8. doi: 10.1017/S0033291718002325. [Epub ahead of print].
Fincham-Campbell S. Kimergård A. Wolstenholme A. Blackwood R. Patton R. Dunne J. Deluca P. Drummond C. (2018). A national survey of assertive outreach treatment services for people who frequently attend hospital due to alcohol-related reasons in England. Alcohol and Alcoholism. 53(3):277-281. doi: 10.1093/alcalc/agx095. (and to come out of 2017 list)
Freeman T.P. Groshkova T. Cunningham A. Sedefov R. Griffiths P. Lynksey M.T. (2018). Increasing potency and price of cannabis in Europe, 2006-2016.Addiction. doi: 10.1111/add.14525. [Epub ahead of print].
GBD 2016 Alcohol and Drug Use Collaborators. (2018). The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. 5(12):987-1012. doi: 10.1016/S2215-0366(18)30337-7.
Gilchrist G. Dennis F. Radcliffe P. Henderson J. Howard L.M. Gadd D. (2018). The interplay between substance use and intimate partner violence perpetration: A meta-ethnography. International Journal of Drug Policy. 65:8-23. doi: 10.1016/j.drugpo.2018.12.009.
Gravely S. Thrasher J.F. Cummings K.M. Ouimet J. McNeill A. Meng G. Lindblom E.N. Loewen R. O'Connor R. Thompson M.E. Hitchman S.C. Hammond D. Heckman B.W. Borland R. Yong H.H. Elton-Marshall T. Bansal-Travers M. Gartner C. Fong G.T. (2018). Discussions between health professionals and smokers about nicotine vaping products: Results from the 2016 ITC Four Country Smoking and Vaping Survey. Addiction. doi: 10.1111/add.14527. [Epub ahead of print].
Hall W. (2018). Minimizing the adverse public health effects of cannabis legalization.Canadian Medical Association Journal. 90(35):E1031-E1032. doi: 10.1503/cmaj.181035.
Hall W.D. Farrell M. (2018). The challenges in providing safe, effective, affordable cannabis-based medicines for unapproved indications. Medical Journal of Australia. 209(5):209-210.
Hall W.D. Farrell M. (2018). Reducing the opioid overdose death toll in North America. PLoS Med. 15(7):e1002626. doi: 10.1371/journal.pmed.1002626. eCollection 2018 Jul.
Harris M. Brathwaite R. Scott J. Gilchrist G. Ciccarone D. Hope V. McGowan C.R. (2018). Drawing attention to a neglected injecting-related harm: a systematic review of AA amyloidosis among people who inject drugs. Addiction.113(10):1790-1801. doi: 10.1111/add.14257.
Harris M. Brathwaite R. McGowan C.R. Ciccarone D. Gilchrist G. McCusker M. O'Brien K. Dunn J. Scott J. Hope V. (2018). 'Care and Prevent': rationale for investigating skin and soft tissue infections and AA amyloidosis among people who inject drugs in London. Harm Reduction Journal. 15(1):23. doi: 10.1186/s12954-018-0233-y.
Heckman B.W. Fong G.T. Borland R. Hitchman S. O'Connor R.J. Bickel W.K. Stein J.S. Yong H.H. Nahhas G.J. Pope D.A. Shang C, Cheng KW, Levy DT, Cummings KM. The impact of vaping and regulatory environment on cigarette demand: behavioral economic perspective across four countries. Addiction. doi: 10.1111/add.14538. [Epub ahead of print].
Hines L.A. Morley K.I. Rijsdijk F. Strang J. Agrawal A. Nelson E.C. Statham D. Martin N.G. Lynskey M.T. (2018). Overlap of heritable influences between cannabis use disorder, frequency of use and opportunity to use cannabis: trivariate twin modelling and implications for genetic design. Psychol Med. 48(16):2786-2793. doi: 10.1017/S0033291718000478 ADD PAGINATION TO ORIGINAL ENTRY already in list
Hobbs M. Kalk N.J. Morrison P.D. Stone J.M. (2018). Spicing it up - synthetic cannabinoid receptor agonists and psychosis - a systematic review. European Neuropsychopharmacology. 28(12):1289-1304. doi: 10.1016/j.euroneuro.2018.10.004
Khadjesari Z. Stevenson F. Toner P. Linke S. Milward J. Murray E. (2018). 'I'm not a real boozer': a qualitative study of primary care patients' views on drinking and its consequences. Journal of Public Health. doi: 10.1093/pubmed/fdy067. [Epub ahead of print]
Lucke J. Jensen C. Dunn M. Chan G. Forlini C. Kaye S. Partridge B. Farrell M. Racine E. Hall W. (2018). Non-medical prescription stimulant use to improve academic performance among Australian university students: prevalence and correlates of use. BMC Public Health. 18(1):1270. doi: 10.1186/s12889-018-6212-0.
Madden A. Hopwood M. Neale J. Treloar C. (2018). Beyond interferon side effects: What residual barriers exist to DAA hepatitis C treatment for people who inject drugs? PLoS One. 13(11):e0207226. doi: 10.1371/journal.pone.0207226.
Middleton A. Milne R. Thorogood A. Kleiderman E. Niemiec E. Prainsack B. Farley L. Bevan P. Steed C. Smith J. Vears D. Atutornu J. Howard H.C. Morley K.I. (2018). Attitudes of publics who are unwilling to donate DNA data for research. European Journal of Medical Genetics. doi: 10.1016/j.ejmg.2018.11.014. [Epub ahead of print].
Milward J. Deluca P. Drummond C. Kimergård A. (2018). Developing typologies of user engagement with the BRANCH alcohol-harm reduction smartphone app: Qualitative study. JMIR Mhealth Uhealth. 6(12):e11692. doi: 10.2196/11692.
Neale J. Parkman T. Strang J. (2018). Challenges in delivering personalised support to people with multiple and complex needs: qualitative study. Journal of Interprofessional Care.10:1-10. doi: 10.1080/13561820.2018.1553869.
Neale J. Tompkins C.N.E. McDonald R. Strang J. (2018). Patient views of opioid pharmacotherapy biodelivery systems: Qualitative study to assist treatment decision making. Patient views of opioid pharmacotherapy biodelivery systems: Qualitative study to assist treatment decision making. Experimental and Clinical Psychopharmacology. 26(6):570-581. doi: 10.1037/pha0000217.
Neale J. Tompkins C.N.E. McDonald R. Strang J. (2018). Implants and depot injections for treating opioid dependence: Qualitative study of people who use or have used heroin. Drug and Alcohol Dependence. 2018 Aug 1;189:1-7. doi: 10.1016/j.drugalcdep.2018.03.057.
Neale J. Tompkins C.N.E. Marshall A.D. Treloar C. Strang J. (2018). Building on feminist achievements to enhance choice for women seeking treatment. Addiction. 113(6):1001-1002. doi: 10.1111/add.14226.
Neale J. Brown C. Campbell A.N.C. Jones J.D. Metz V.E. Strang J. Comer S.D. (2019). How competent are people who use opioids at responding to overdoses? Qualitative analyses of actions and decisions taken during overdose emergencies.Addiction. 114(4):708-718. doi: 10.1111/add.14510.
Reed K. Knight A. Baillie S. Bogdanowicz K. Bell J. Strang J. (2018). Switching between lyophilized and sub-lingual bprenorphine formulations in opioid-dependent patients: Observations on medication transfer during a safety and pharmacokinetic study. Heroin Addiction and Related Clinical Problems. 20(5):19-28.
Robertson R. McAuley A. Macleod J. Strang J. McCallum A. (2018). Drugs policy will not change as long as UK government refuses to acknowledge the need for change. British Medical Journal. 361:k2604. doi: 10.1136/bmj.k2604.
Thomas D. Farrell M. McRobbie H. Tutka P. Petrie D. West R. Siahpush M. Gartner C. Walker N. Mendelsohn C.P. Hall W. Paul C. Zwar N. Ferguson S.G. Boland V.C. Richmond R. Doran C.M. Shakeshaft A. Mattick R.P. Courtney R.J. (2018). The effectiveness, safety and cost-effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non-inferiority trial. Addiction. doi: 10.1111/add.14541. [Epub ahead of print].
Thompson M.E. Fong G.T. Boudreau C. Driezen P. Li G. Gravely S. Cummings K.M. Heckman B.W. O'Connor R. Thrasher J.F. Nahhas G. Borland R. Yong H.H. McNeill A. Hitchman S.C. Quah A.C.K. (2018). Methods of the ITC Four Country Smoking and Vaping Survey, Wave 1 (2016). Addiction. doi: 10.1111/add.14528. [Epub ahead of print].
Walters R.K. Polimanti R. Johnson E.C. McClintick J.N. Adams M.J. Lynskey M.T. Agrawal A. (2018). Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders. Nature Neuroscience. 21(12):1656-1669. doi: 10.1038/s41593-018-0275-1.
(As of 26th Apr 2019)